Hiprex 1g tablets

Ország: Egyesült Királyság

Nyelv: angol

Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktív összetevők:

Methenamine hippurate

Beszerezhető a:

Viatris UK Healthcare Ltd

ATC-kód:

J01XX05

INN (nemzetközi neve):

Methenamine hippurate

Adagolás:

1gram

Gyógyszerészeti forma:

Oral tablet

Az alkalmazás módja:

Oral

Osztály:

No Controlled Drug Status

Recept típusa:

Valid as a prescribable product

Termék összefoglaló:

BNF: 05011300; GTIN: 0000050485826

Betegtájékoztató

Patient Information Leaflet
Hiprex 1g tablets
Methenamine hippurate
Read all of this leaflet carefully before you start taking this
medicine because it
contains
important information for you.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even
if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Hiprex is and what it is used for
4. Possible side effects
2. What you need to know before you take Hiprex
5. How to store Hiprex
3. How to take Hiprex
6. Contents of the pack and other information.
1. What Hiprex is and what it is used for
Hiprex contains the active substance methenamine hippurate and belongs
to a group of medicines
called anti-bacterials. These work by killing many different types of
bacteria which cause infections.
Hiprex is used to treat infections of the urinary tract and stop them
from coming back. The urinary tract
is a collective name for the parts of the body that produce, store and
transport urine. These include the
kidney, bladder and tubes called the ureter and urethra. It is also
used to avoid urinary tract infections
in patients with catheters from their bladders (a tube that helps with
incontinence) and in people
undergoing certain medical procedures.
2. What you need to know before you take Hiprex
Do not use Hiprex if:
•
You are allergic to methenamine hippurate or any of the other
ingredients of this medicine (listed in
section 6)
•
You are taking antibiotic medicines called sulphonamides. These can
damage your
kidneys when
taken at the same time as Hiprex
•
You are severely dehydrated
•
You have serious problems with your kidneys
•
You have problems with your liver
•
You have gout
•
You have a condition called metabolic acid

Termékjellemzők

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Hiprex 1 g Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Hiprex tablet contains methenamine hippurate 1 g.
For the full list of excipients, see 6.1.
3 PHARMACEUTICAL FORM
A white to creamy-white oblong shaped tablet coded HX with break line
on one
face and break line on the other face with or without 3M.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Hiprex is indicated in the prophylaxis and treatment of urinary tract
infections:
As maintenance therapy after successful initial treatment of acute
infections with
antibiotics.
As long-term therapy in the prevention of recurrent cystitis.
To suppress urinary infection in patients with indwelling catheters
and to reduce the
incidence of catheter blockage.
To provide prophylaxis against the introduction of infection into the
urinary tract
during instrumental procedures.
Asymptomatic bacteriuria.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults: _1g twice daily.
In patients with catheters the dosage may be increased to 1g three
times daily.
_Paediatric population:_
_Children under 6 years: _Not recommended.
_Children: 6-12 years: _500mg twice daily.
_Older people: _
_ _
No special dosage recommendations.
Method of administration
The tablets may be halved, or they can be crushed and taken with a
drink of milk or
fruit juice if the patient prefers.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in section
6.1.
Hepatic dysfunction, renal parenchymal infection, severe dehydration,
metabolic
acidosis, severe renal failure (creatinine clearance or GFR<10
ml/min.) or gout.
Hiprex may be used where mild (20-50 ml/min.) to moderate (10-20
ml/min.) renal
insufficiency is present. (If the GFR is not available the serum
creatinine
concentration can be used as a guide.). Hiprex should not be
administered
concurrently with sulphonamides because of the possibility of
crystalluria, or with
alkalising agents, such as a mixture of potassium citrat